Avaliação da técnica de esfoliação com escova citológica para coleta de células conjuntivais em gatos sadios: comparação entre a face palpebral da membrana nictitante e a conjuntiva palpebral

A citologia conjuntival é um importante meio de diagnóstico de afecções da superfície ocular. Buscam-se técnicas que forneçam quantidade e qualidade celular, com uso de instrumentos que provoquem mínimo trauma e que diminuam as chances de danos iatrogênicos ao olho. Existem diversas técnicas de coleta de células, entre elas encontram-se: impressão, esfoliação e punção por agulha fina. Dentre os métodos utilizados para esfoliação, o uso da escova citológica fornece resultados superiores em vários parâmetros, incluindo a qualidade das células. Estudou-se a citologia conjuntival por esfoliação com escova citológica, utilizada para coleta de material da cérvix uterina, tendo como objetivos determinar se tal instrumento se adequaria à coleta de material da face palpebral da membrana nictitante e da conjuntiva palpebral de felinos sadios. Foram avaliados os seguintes parâmetros: facilidade de execução da técnica, possibilidade de ocorrência de danos iatrogênicos e quantidade e qualidade de células coletadas. Cinquenta gatos machos (58%) e fêmeas (42%), com ou sem raça definida, participaram do estudo. Apenas gatos isentos de alterações oculares no exame físico foram incluídos. A escova citológica se mostrou um instrumento de fácil utilização, que fornece células em quantidade satisfatória e com morfologia preservada. Comparada a conjuntiva palpebral, a face palpebral da membrana nictitante se mostrou um local mais adequado à realização da coleta de amostras citológicas, pela maior facilidade de execução da técnica e menor possibilidade de danos iatrogênicos. No que diz respeito à quantidade e qualidade celular, não houve diferença significativa entre os dois locais de coleta. Foi possível observar células provenientes das diferentes camadas do epitélio conjuntival com predomínio de células intermediárias e ausência de células caliciformes

Microsurgical techniques for the treatment of breast cancer-related lymphedema: a systematic review

Item does not contain fulltextBACKGROUND: Upper limb lymphedema is one of the most underestimated and debilitating complications of breast cancer treatment. The aim of this review is to summarize the recent literature for evidence of the effectiveness of lymphatic microsurgery for the treatment of breast cancer-related lymphedema (BCRL). METHODS: A search was conducted for articles published from January 2000 until January 2012. Only studies on secondary lymphedema after breast cancer treatment and those examining the effectiveness of microsurgery were included. RESULTS: No randomized clinical trials or comparative studies were available. Ten case-series met inclusion criteria: (composite) tissue transfer (n = 4), lymphatic vessel transfer (n = 2), and derivative microlymphatic surgery (n = 4). Limb volume/circumference reduction varied from 2 to 50% over a follow-up time ranging from 1 to 132 months. Postoperative discontinuation rates of conservative therapy were only reported after composite tissue transfer, ranging from 33 to 100% after 3 to 24 months. Clear selection criteria for lymphatic surgery and lymphatic flow assessment were absent in most studies. CONCLUSION: We identified important methodological shortcomings of the available literature. Evidence acquired through comparative studies with uniform patient selection is lacking. Consistent positive findings with regards to limb volume reduction and limited complications are reasons to further explore these techniques in methodologically superior studies

A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA).

BACKGROUNDS: To determine the true incidence of hGISA/GISA and its consequent clinical impact, methods must be defined that will reliably and reproducibly discriminate these resistant phenotypes from vancomycin susceptible S. aureus (VSSA). METHODS: This study assessed and compared the ability of eight Dutch laboratories under blinded conditions to discriminate VSSA from hGISA/GISA phenotypes and the intra- and inter-laboratory reproducibility of agar screening plates and the Etest method. A total of 25 blinded and unique strains (10 VSSA, 9 hGISA and 6 GISA) were categorized by the PAP-AUC method and PFGE typed to eliminate clonal duplication. All strains were deliberately added in quadruplets to evaluate intra-laboratory variability and reproducibility of the methods. Strains were tested using three agar screening methods, Brain Heart Infusion agar (BHI) + 6 microg/ml vancomycin, Mueller Hinton agar (MH) + 5 microg/ml vancomycin and MH + 5 microg/ml teicoplanin) and the Etest macromethod using a 2 McFarland inoculum. RESULTS AND DISCUSSION: The ability to detect the hGISA/GISA phenotypes varied significantly between methods and phenotypes. BHI vancomycin and MH vancomycin agar screens lacked the ability to detect hGISA. The MH teicoplanin agar screen was more sensitive but still inferior to Etest that had a sensitivity of 98.5% and 99.5%, for hGISA and GISA, respectively. Intra- and inter-laboratory reproducibility varied between methods with poorest performance seen with BHI vancomycin. CONCLUSION: This is the first multi-center blinded study to be undertaken evaluating various methods to detect GISA and hGISA. These data showed that the ability of clinical laboratories to detect GISA and hGISA varied considerably, and that screening plates with vancomycin have a poor performance in detecting hGISA